Clinical-immunological and neurophysiological correlations in paraneoplastic polyneuropathy caused by small cell lung cancer-Reference-Cited by-同舟云学术

Clinical-immunological and neurophysiological correlations in paraneoplastic polyneuropathy caused by small cell lung cancer

Published:2023-03-28 Issue:1 Volume:20 Page:75-83
ISSN:2708-6011
Container-title:Health and Ecology Issues
language:
Short-container-title:jour

Author:

Ponomarev V. V.¹^ORCID,Reduto E. V.²^ORCID

Affiliation:

1. Belarusian Medical Academy of Postgraduate Education

2. Brest Central Polyclinic

Abstract

Objective. To study the correlation between the neurological, immunological and neurophysiological signs of paraneoplastic polyneuropathy (PPNP) caused by small cell lung cancer (SCLC), to improve the quality of diagnosis of this pathology.Materials and methods. Clinical, immunological (anti-Hu) and neurophysiological (electromyography (EMG), electroneuromyography (ENMG), somatosensory evoked potentials (SSEP)) examination of 61 patients with PPNP caused by SCLC are presented.Results. It was established that sensory disorders in the limbs are the first and obligate clinical symptoms of PPNP, which precede the initial diagnosis of SCLC in 56% in 3-12 months, characterized by a predominance of a decrease in surface sensitivity in the form of distal hypoesthesia in 70% of cases. The motor form is characterized by an older age (67 years) than the sensory (60 years) and sensorimotor (58.0 years, p <0,05). Motor disorders in the limbs occur in 46% of cases, manifested by mild symmetrical distal paresis of the legs and subclinical damage to the motor nerves of the upper extremities according to the results of ENMG (p <0,001). Detection of anti-Hu in plasma is highly correlated with a significant increase in latency and a decrease in amplitudes component N22 in the conduct of SSEP, which indicates the defeat of the axons of the sensory nerves of the limbs (p <0,05). Changes in amplitude parameters, with preserved speed indicators of nerves according to the results of ENMG indicate an axonal type of lesion (p <0,05), which, in combination with the detection of anti-Hu in plasma, are pathognomonic signs of the paraneoplastic nature of the process.Conclusion. As a result of the study, clinical, immunological and neurophysiological features of various forms of PPNP were identified. The obtained correlations make it possible to diagnose the corresponding type of nerve pathology more accurately and in a timely manner and to suspect the development of oncological disease in time. The revealed changes in the indicators of the N22 component of SSEP can serve as a marker of axonal lesion of peripheral nerves, which with high diagnostic efficiency justifies the expediency of inclusion in the protocol of the ENMG study for verification of additional signs characteristic of PPNP.

Publisher

Gomel State Medical University

Reference15 articles.

1. Evtushenko SK. Paraneoplastic neurological syndromes (clinic, diagnostics, treatment). Mezhdunar neurol journal. 2011;(8):9-21. (in Russ.).

2. Koroleva ES. Paraneoplastic polyneuropathy in patients with lung and breast cancer: autoref. dis. cand. honey. Sciences. Tomsk, 2013. 27 p. (in Russ.).

3. Koroleva ES, Losenkov IS, Alifirova VM, et al. Diagnosis of paraneoplastic polyneuropathy in patients with breast cancer and small cell lung cancer. J. Neurology and Psychiatry named S.S. Korsakov.2014;114(4): 93-96. (in Russ.).

4. Ponomarev VV, Selitsky MM, Reduto EV, Lukashevich NV. Autoimmune polyneuropathies and multiple mononeuropathies. Minsk, 202. 39 p. (in Russ.).

5. Schneider NA, Dykhno YuA, Ezhikova VV. Clinical heterogeneity of paraneoplastic neurological syndrome. Sibir onkol journal. 2011;(3):82-89. (in Russ.).